Investor Presentation First Nine Months of 2022

116 Investor presentation First nine months of 2022 Diabetes market share and market growth in EMEA 75% 50% 25% Diabetes market growth and Novo Nordisk market share 0% Aug 2019 NN market share -Market growth (right axis) EMEA DKK billion Diabetes market size and growth -15% 20% 18% 6 111 4 5 96 15% 15% 34% 10% 29% 5% ~18% 29% 28% 0% Aug Aug Novo Nordisk AZ Others Aug 2022 2021 2022 Novo Nordisk Competitors NN share of growth NN growth (right axis) Source: IQVIA, Aug 2022, Value, MAT, EMEA: Europe, Middle East and Africa; NN: Novo Nordisk; AZ- Astra Zeneca

View entire presentation